.png)
OXON Epidemiology is a full-service Contract Research Organization (CRO) specialising in the generation of Real-World Evidence (RWE) via primary data collection, secondary data and hybrid observational studies, pragmatic trials, synthesis research, and data analysis and modelling of drugs and devices in all major therapeutic areas. As a leading CRO, OXON provides a unique blend of quality science and operational experience to support pharmaceutical and medical devices companies worldwide to obtain high-quality RWE for Safety, Market Access/HEOR and Clinical Development, improving patients’ and public health: • Multi-country field, chart review and database epidemiological studies • Patient registries • Pragmatic Trials • Systematic Reviews & Meta-analysis • PASS and PAES studies • Risk minimisation studies • Risk management • Statistical signal detection & analysis • Quantitative benefit-risk analysis for CTD / PBRER • Patient reported outcomes • Health economics & modelling • Meta-analysis and Evidence strategy We have strong academic links with the London School of Hygiene & Tropical Medicine and leading pharmacoepidemiology consultants in Europe, being among OXON staff publications: Lancet (x8), JAMA (x1) and BMJ (x3). OXON is a partner centre of ENCePP (European Network of Centres in Pharmacoepidemiology and Pharmacovigilance), which is coordinated by the European Medicines Agency (EMA). We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. Our studies are registered in the EU PAS Register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.